Thus, it remains unclear why BRCA1 mutations are preferentially associated with increased incidence of cancer in only a small subset of tissues rather than a generalized increase in all cancer types, as is observed with other tumour-suppressor proteins involved in DNA damage repair (for example p53, ATM)11, 12. The gene discussed is TP53; the disease is cancer.